GlassScriptPhysician profile
Heather Biede
NPI 1972195915
$6,695.39
in general payments reported to CMS, 2019-2025
14 companies · $2,830 in 2025
The $2,830 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $2,063 · 2024: $1,803 · 2025: $2,830.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,044 · Travel and Lodging: $651.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,044.43 |
| Travel and Lodging | $650.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $3,301.74 | 2023-2025 | Dovato, Apretude, Cabenuva |
| Gilead Sciences, INC. | $1,834.05 | 2023-2025 | Descovy, Biktarvy |
| Abbvie INC. | $479.33 | 2023-2025 | |
| Novo Nordisk INC | $291.25 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Theratechnologies INC. | $194.02 | 2023-2025 | Trogarzo, Egrifta |
| Merck Sharp & Dohme LLC | $172.81 | 2023-2025 | Pifeltro, Delstrigo, Capvaxive |
| Napo Pharmaceuticals INC | $157.08 | 2023-2025 | Mytesi |
| Lilly USA, LLC | $126.51 | 2023-2025 | Mounjaro |
| Emd Serono, INC. | $50.00 | 2024 | Serostim |
| Phadia US INC. | $24.81 | 2023 | Immunocap |
| Axsome Therapeutics, INC. | $20.03 | 2023 | Auvelity |
| Globus Medical, INC. | $16.75 | 2024 | Mlx |
| Astrazeneca Pharmaceuticals LP | $13.87 | 2025 | Breztri |
| Currax Pharmaceuticals LLC | $13.14 | 2023 | Contrave, Onzetra Xsail |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Biede listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.